Literature DB >> 24418643

Malignant peripheral nerve sheath tumor: pathology and genetics.

Khin Thway1, Cyril Fisher2.   

Abstract

Malignant peripheral nerve sheath tumors are soft tissue neoplasms that show differentiation toward cells of the nerve sheath. They often arise from peripheral nerves or preexisting benign nerve sheath tumors and are generally high-grade neoplasms, which behave aggressively with high incidence of distant metastases. Malignant peripheral nerve sheath tumor can be histologically diverse and is difficult to diagnose because of its morphological overlap with a variety of other sarcomas and its lack of specific immunohistochemical markers or genetic profile. We review the pathology of malignant peripheral nerve sheath tumor, with reference to etiology, molecular genetics, and clinical factors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Malignant peripheral nerve sheath tumor; Neurofibromatosis type 1; Neurofibrosarcoma; Sarcoma; Triton tumor

Mesh:

Substances:

Year:  2013        PMID: 24418643     DOI: 10.1016/j.anndiagpath.2013.10.007

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  21 in total

Review 1.  [Soft tissue tumors in hereditary tumor syndromes].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

Review 2.  Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.

Authors:  Lama Binobaid; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

Review 3.  Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities.

Authors:  Matthew J McBride; Cigall Kadoch
Journal:  J Pathol       Date:  2018-03-06       Impact factor: 7.996

Review 4.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

5.  Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.

Authors:  Carlos N Prieto-Granada; Thomas Wiesner; Jane L Messina; Achim A Jungbluth; Ping Chi; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

6.  Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors.

Authors:  Slawomir Antoszczyk; Samuel D Rabkin
Journal:  Expert Opin Orphan Drugs       Date:  2015-12-26       Impact factor: 0.694

7.  Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses.

Authors:  Julian Zipfel; Meizer Al-Hariri; Isabel Gugel; Karin Haas-Lude; Alexander Grimm; Steven Warmann; Michael Krimmel; Victor-Felix Mautner; Marcos Tatagiba; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2020-06-06       Impact factor: 1.475

8.  BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features.

Authors:  Doron Tolomeo; Antonio Agostini; Gemma Macchia; Alberto L'Abbate; Marco Severgnini; Ingrid Cifola; Maria Antonia Frassanito; Vito Racanelli; Antonio Giovanni Solimando; Felix Haglund; Fredrik Mertens; Clelia Tiziana Storlazzi
Journal:  Hum Cell       Date:  2020-08-27       Impact factor: 4.174

Review 9.  Malignant peripheral nerve sheath tumor of the bladder A case report.

Authors:  G Petracco; C Patriarca; R Spasciani; A Parafioriti
Journal:  Pathologica       Date:  2019-12

10.  TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions.

Authors:  Gun-Hoo Park; Su-Jin Lee; Hyunee Yim; Jae-Ho Han; Hyon J Kim; Young-Bae Sohn; Jung Min Ko; Seon-Yong Jeong
Journal:  Oncol Rep       Date:  2014-08-04       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.